The effect of taurine in reducing the incidence of ventilator-associated pneumonia

Phase 3

Recruiting

Conditions: Ventilator-associated pneumonia.
Ventilator associated pneumonia
J95.851

Registration Number: IRCT20120731010453N4

Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 72

Inclusion Criteria

Willingness to participate in the study and complete the ethical consent form by the parents.
All children aged 3 months to 15 years who need mechanical ventilation for more than 48 hours.

Exclusion Criteria

Malignancy, AIDS
Patients with heart failure
Age less than three months
Cystic fibrosis patients

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The incidence of ventilator-associated pneumonia. Timepoint: During the intubation period of the patient in the intensive care unit. Method of measurement: Based on the criteria of ventilator-associated pneumonia (doctor's clinical suspicion, patient's tests, patient's radiograph, and culture results).

Secondary Outcome Measures

Name	Time	Method
The incidence of septic shock. Timepoint: As long as the patient is in the intensive care unit. Method of measurement: Diagnosis and confirmation by the doctor.